Abiraterone
Back to searchMolecule Structure
Scientific Name
Abiraterone
Description of the Drug
Abiraterone is an antiandrogen used in the treatment of prostate cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05812
http://www.drugbank.ca/drugs/DB05812
Brand Name(s)
Zytiga
Company Owner(s)
Not Available
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cytochrome P450 17A1 | SINGLE PROTEIN | INHIBITOR | CHEMBL3522 |
Steroid 5-alpha-reductase | PROTEIN FAMILY | INHIBITOR | CHEMBL2363075 |
Androgen Receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1871 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL61108 |
PharmGKB | PA166123407 |
DrugBank | DB05812 |
PubChem: Thomson Pharma | 14925329 |
PubChem | 132971 |
Nikkaji | J617.457D |
PDBe | AER |
BindingDB | 25458 |
EPA CompTox Dashboard | DTXSID80879993 |
ChemicalBook | CB01320705 |
Guide to Pharmacology | 6745 |
rxnorm | ABIRATERONE |
ChEBI | 68642 |
ZINC | ZINC000003797541 |